What's next for an HIV vaccine?

Cutting-edge developments in HIV vaccine research: New insights and implicationsПодробнее

Experimental HIV Vaccine Successfully Triggers Potent Antibodies in HumansПодробнее

Trial HIV vaccine triggers elusive and essential antibodies, pointing the way toward a successfulПодробнее

Global HIV Vaccine Enterprise Annual Stakeholder Meeting: HIV vaccine cannot be ‘business as usual’Подробнее

IAS 2023 Day 3 Dr. Carl Dieffenbach Shares Updates on HIV Vaccine Research & bnAbsПодробнее

An mRNA twist to the HIV vaccine problemПодробнее

HIV Three trials to watch in 2024Подробнее

What's Next for the World's First HIV Vaccine?Подробнее

Lab to the Jab: Lessons learned and what’s next in HIV vaccine researchПодробнее

IAVI has led the search for an HIV vaccine since our founding in 1996Подробнее

HIV Vaccine Awareness Day 2022 | AfNHIПодробнее

HIV Vaccine Landscape | Larry Corey, MDПодробнее

Global HIV Vaccine Enterprise annual stakeholders meeting: Accelerating early phase vaccine researchПодробнее

The HIV Vaccine Clinical Trial ExplainedПодробнее

mRNA Vaccine Technology and the Prospects for an HIV VaccineПодробнее

A new approach to the HIV vaccine has shown promise in its first-in-human trial (S2E13)Подробнее

What's next for an HIV vaccine?Подробнее

Next HIV Treatment | LX NewsПодробнее

#TeamVaccines – #VaccinesForLife: HIV Vaccines – The next frontier in virus preventionПодробнее

HIV Treatments Update Seminar 2021 - HIV Vaccine FuturesПодробнее